FDA approves 2 drugs for deadly lung disease

Published



WASHINGTON (AP) — The Food and Drug Administration has approved the first drug treatments for a deadly disease that causes severe lung damage.

The agency on Wednesday approved two novel treatments from Boehringer Ingelheim and Roche for idiopathic pulmonary fibrosis. Patients with the disease experience lung damage over time that makes it difficult to breathe properly. Currently the disease is treatment with oxygen therapy, rehabilitation and lung transplants.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.